-
Ticagrelor Hub: when to use and which dose?
November 28, 2021The dosage and indications of Ticagrelor
-
Cardiometabolic Grand round, Session 5
November 21, 2021The 5th session of Cardiometabolic grand round
-
Primary prevention in dyslipidemia as the only cardiovascular risk factor
November 4, 2021Dyslipidemia in primary prevention of low-risk patients
-
Late-breaking Science in Cardiovascular disease prevention
November 2, 2021ESC 2021 cardiovascular prevention guideline lectures and discussion
-
Management of dyslipidemia in diabetic patients
October 24, 2021DLP and T2DM: approach and management
-
DiaBeat: The Beating Heart of Diabetes (8th session)
October 19, 20218th Diabetes Masterclass for Cardiologists
-
The clinical landscape for Diabetes and Cardiovascular disease
August 24, 2021T2DM and cardiovascular diseases: The clinical landscape
-
DiaBeat: The Beating Heart of Diabetes (7th session), a scientific debate
August 14, 20217th Diabetes Masterclass for Cardiologists
-
From optimal medical therapy to revascularization in CCS
August 14, 2021Choosing the best therapeutic strategy in CCS
-
Antithrombotic lighthouse, Cases and Faces: antithrombotic therapy in CAD
August 14, 2021Antithrombotic regimens in CAD
-
Symptom matters: angina control in coronary artery disease
August 14, 2021From surrogates to symptom control in CAD
-
Tailored Antithrombotic therapy for CCS patients
July 25, 2021Best individual antithrombotic strategy in CCS
-
Marking the antiplatelet therapy maze in ACS
July 12, 2021How to prevent atherosclerotic cardiovascular events
-
DiaBeat: The Beating Heart of Diabetes (6th session)
June 24, 20216th Diabetes Masterclass for Cardiologists
-
Cardiometabolic Grand Round: 4th session
June 24, 2021Guideline-directed cardiovascular evaluations before surgery
-
Cardiovascular complications of T2DM: the preventive role of SGLT2Is
June 20, 2021SGLT2Is and the prevention of cardiovascular complications in T2DM
-
DCS 1400: session 8, Valvular Heart disease
June 16, 2021The eighth panel of DCS 1400: Valvular Heart disease
-
DCS 1400: session 7, VTE
June 16, 2021The seventh panel of DCS 1400: Venous Thromboembolism
-
DCS 1400: session 6, Arrhythmia
June 16, 2021The sixth panel of DCS 1400: Arrhythmia
-
DCS 1400: session 5, HF
June 16, 2021The fifth panel of DCS 1400: Heart Failure
-
DCS 1400: session 4, ACS
June 16, 2021The fourth panel of DCS 1400: Acute coronary syndrome
-
DCS 1400: session 3, CCS
June 16, 2021The third panel of DCS 1400: Chronic coronary syndrome
-
DCS 1400: session 2, Diabetes for cardiologists
June 16, 2021The second panel of DCS 1400: diabetes for cardiologists
-
DCS 1400: session 1, HTN and DLP
June 16, 2021The first panel of DCS 1400: hypertension and dyslipidemia
-
DCS 1400: welcome remarks
June 16, 2021The initial greetings of DCS 1400
-
How to reduce the atherosclerotic cardiovascular risk
May 18, 2021A case-based Review on HTN and DLP management
-
The evolution of antiplatelet therapy in CAD: a 45 year journey
May 10, 2021A brief history of anti-platelet therapy in CAD
-
Dual antiplatelet therapy in2021: Current recommendations
May 10, 2021The latest updates on DAPT
-
DiaBeat: The Beating Heart of Diabetes (5th session)
May 1, 20215th Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (4th session)
April 12, 20214th Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (3rd session)
April 12, 20213rd Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (2nd session)
April 11, 20212nd Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (1st session)
April 10, 20211st Diabetes Masterclass for Cardiologists
-
PCSK9 inhibitors place in patients with cardiometabolic diseases
March 16, 2021PCSK9 inhibitors from two perspectives of Endocrinologist & Cardiologist
-
Cardiometabolic Grand Round (3)
February 27, 2021A brief talk on DM medication challenges in patients with CVD
-
Introduction: Evolution of DOACs and their place in Guidelines
January 21, 2021A brief report of Guidelines mentioned DOACs place in practice
-
10th Case: Drug Drug Interactions
January 21, 2021DOACs important interactions in clinical practice
-
To DOAC or Not to DOAC
January 21, 2021Rapid review of oral anticoagulation practice in different clinical scenarios
-
9th Case: Renal Insufficiency
January 21, 2021OAC Management in Patients with CKD
-
8th Case: Intracranial Bleed
January 21, 2021OAC Choice in High Thrombotic Risk Patients after ICH
-
Seventh Case: Thrombocytopenia
January 21, 2021Any Concerns for OACs Use in Patients with Thrombocytopenia
-
Sixth Case: Hepatic Impairment
January 21, 2021OAC of choice in patients with hepatic impairment, any difference between DOACs?
-
Fifth Case: Stable ASCVD
January 21, 2021Low dose Rivaroxaban in SIHD, COMPASS trial
-
Forth Case: Extreme Body Weights
January 21, 2021OAC choice in patients with obesity or low body weights, any role for DOACs?
-
Third Case: AF & Artificial Heart Valves
January 21, 2021OAC of choice in patients with artificial heart valves
-
Second Case: Cancer associated VTE
January 21, 2021Anticoagulation of choice in patients with cancer, the importance of DDI
-
First Case: Elective PCI and AF
January 21, 2021Antithrombotic regimen of choice in patients with AF undergoing elective PCI
-
Complete Session;SGLT2 inhibition: Making waves in the heart failure landscape
January 12, 2021Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
SGLT2 inhibitors in the treatment of HF: the future is bright?
January 12, 2021Cardiologist Perspective on SGLT2 inhibitors
-
SGLT2 inhibition: A snapshot into their evolution
January 12, 2021Endocrinologist Perspective on SGLT2 inhibitors
-
SGLT2 inhibition: Making waves in the heart failure landscape
January 12, 2021Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
Residents’ Island: Abidi CVD Prevention Academy
January 12, 2021Multidisciplinary approach to CVD Prevention
-
Cardiometabolic Grand Round (2)
December 7, 2020A brief talk on DM medication challenges in patients with CVD
-
Cardiometabolic Grand Round (1)
November 1, 2020A brief talk on DM management in patients with CVD
-
How to Implement the Newest Diabetes Therapies in HF Treatment
October 29, 2020New insight from EMPEROR Reduced Trial
-
Paradigm Shift in Treating Intermediate Risk Pulmonary Embolism
October 29, 2020Concise Talk on Intermediate Risk Pulmonary Embolism, update by an expert in the field
-
What we learned from ESC Congress about HTN Management
October 22, 2020A Brief Discussion on HTN Management Pearls of ESC 2020
-
VTE Prophylaxis in Patients with COVID-19
October 19, 2020Challenges on VTE Prophylaxis in different settings (inpatient, outpatient, upon discharge)
-
ESC 2020 Congress Coverage What is new on NSTE-ACS Guideline: a panel discussion
October 2, 2020Brief Discussion on the New ESC Guideline on NSTE-ACS
-
Diabetes and Cardiovascular Diseases
September 29, 2020On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors
-
Smoking and the Heart the Struggle Continues
September 29, 2020On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors
-
The weight of the world: The global challenge of obesity
September 29, 2020On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors
-
Ground-breaking research from ESC Congress 2020 (23)
September 16, 2020Part Twenty-three: Trial Review, ELDERCARE-AF
-
Ground-breaking research from ESC Congress 2020 (22)
September 16, 2020Part Twenty-Two: Trial Review, ATPCI
-
Ground-breaking research from ESC Congress 2020 (21)
September 16, 2020Part Twenty-One: Trial Review, BPLTTC (CANCER)
-
Ground-breaking research from ESC Congress 2020 (20)
September 16, 2020Part Twenty: Trial Review, POPULAR TAVI
-
Ground-breaking research from ESC Congress 2020 (19)
September 16, 2020Part Nineteen: Trial Review, EXPLORER-HCM
-
Ground-breaking research from ESC Congress 2020 (18)
September 16, 2020Part Eighteen: Trial Review, HOME-PE
-
Ground-breaking research from ESC Congress 2020 (17)
September 16, 2020Part Seventeen: Trial Review, REALITY
-
Ground-breaking research from ESC Congress 2020 (16)
September 16, 2020Part Sixteen: Trial Review, BPLTTC
-
Ground-breaking research from ESC Congress 2020 (15)
September 16, 2020Part Fifteen: Trial Review, PARALLAX
-
Ground-breaking research from ESC Congress 2020 (14)
September 16, 2020Part Fourteen: Trial Review, POPULAR CABG
-
Ground-breaking research from ESC Congress 2020 (13)
September 16, 2020Part Thirteen: Trial Review, BAMI
-
Ground-breaking research from ESC Congress 2020 (12)
September 16, 2020Part Twelve: Trial Review, EVAPORATE
-
Ground-breaking research from ESC Congress 2020 (11)
September 16, 2020Part Eleven: Trial Review, DAPA-CKD
-
Ground-breaking research from ESC Congress 2020 (10)
September 16, 2020Part Ten: Trial Review, DECLARE-TIMI
-
Ground-breaking research from ESC Congress 2020 (9)
September 16, 2020Part Nine: Trial Review, RATE-AF
-
Ground-breaking research from ESC Congress 2020 (8)
September 16, 2020Part Eight: Trial Review, COPS
-
Ground-breaking research from ESC Congress 2020 (7)
September 16, 2020Part Seven: Trial Review, COLCOT
-
Ground-breaking research from ESC Congress 2020 (6)
September 16, 2020Part Six: Trial Review, LoDoCo2
-
Ground-breaking research from ESC Congress 2020 (5)
September 16, 2020Part Five: Trial Review, EAST-AFNET4
-
Ground-breaking research from ESC Congress 2020 (4)
September 16, 2020Part Four: Trial Review, BRACE-CORONA
-
Ground-breaking research from ESC Congress 2020 (3)
September 16, 2020Part Three: Trial Review; THEMIS, PAD
-
Ground-breaking research from ESC Congress 2020 (2)
September 16, 2020Part Two: Trial Review, EMPEROR-REDUCED
-
Ground-breaking research from ESC Congress 2020
September 16, 2020Congress Coverage: Introduction
-
Ground-breaking research from ESC Congress 2020
September 10, 2020Brief Review of Main Trials Discussed in ESC Congress 2020
-
Shielding the Brain From Stroke
August 20, 2020A case based discussion on optimization of antithrombotic therapy in patients with ischemic stroke
-
Current Cardiology Practice of Antithrombotics in ASCVD: A Case Based Panel Discussion
August 18, 2020Brief discussion on choice of antithrombotic agents in patients with chronic coronary syndrome and peripheral artery disease
-
Cardiometabolic Care Network
July 16, 2020Interprofessional Collaboration Practice in Risk Management of ASCVD
-
Optimizing Heart Failure Care Throughout the Patient Journey
June 25, 2020A Case Based Panel Comprehensive Discussion on HF Pharmacotherapy
-
Low-dose Rivaroxaban in Management of PAD Patients
June 23, 2020Insights from COMPASS & VOYAGER Trials
-
Rivaroxaban on Board for Chronic ASCVD
June 23, 2020How DPI Found Its Way into Clinical Practice
-
Low-dose Rivaroxaban in Management of Post-Revascularized CAD Patients
June 23, 2020Insights from COMPASS-PCI & COMPASS-CABG Trials
-
COVID-19 and thrombotic or thromboembolic disease: implication for prevention, antithrombotic therapy, and follow up
May 12, 2020Antithrombotic challenge in patients with COVID-19; focus on JACC State of ART review
-
Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19)Hydroxychloroquine: A magic bullet?
May 10, 2020The role of medications in the pre and post prophylaxis against COVID-19
-
COVID and Cardiometabolic Challenges
April 10, 2020Multidisciplinary approach to COVID-19 Cardiometabolic Complications
-
The evolving pandemic of COVID-19 and invasive cardiology consideration
April 6, 2020Brief description of COVID-19 effect on approaching invasive strategies in patients with CVD
-
COVID-19 Cath Lab Implications
March 29, 2020A frontline View from Italy
-
COVID-19 Sharing Facts, Not the Fear
March 3, 2020Quick review on COVID-19 from an ID Perspective
-
Ischemic Cardiomyopathy to be Revascularized and How?
November 19, 2019Pass the torch: Educational sessions for Interventional Cardiologists, Review of ESC 2019 CCS Guideline
-
How to Select Appropriate Testing?
November 19, 2019Pass the torch: Educational sessions for Interventional Cardiologists, Review of ESC 2019 CCS Guideline
-
Anti-ischemic Medications
November 19, 2019Pass the torch: Educational sessions for Interventional Cardiologists, Review of ESC 2019 CCS Guideline
Follow US
Copyright All rights reserved ©2021 Daily Cardiology Academy Team
Design By Tysiz